Log Type Authored on Log Message Log Node Authored by
User created Wed, 10/12/2022 - 13:23 User created Anonymous
User created Wed, 10/12/2022 - 13:23 User created Anonymous
Newsletter opened Thu, 07/30/2020 - 03:57 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Thu, 07/30/2020 - 03:33 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
User created Wed, 10/12/2022 - 13:23 User created Anonymous
User created Wed, 10/12/2022 - 13:23 User created Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Convite Lundbeck Webinar Internacional Anonymous
Newsletter clicked Tue, 11/08/2022 - 12:04 Clicked https://brazil.progress.im/pt-br/content/novos-medicamentos-com-anticorpos-monoclonais-t%C3%AAm-como-alvo-cgrp-e-seus-receptores Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
OWA Status Wed, 10/12/2022 - 13:23 Updating trust level from 1 to 2 Anonymous
Newsletter subscribed Wed, 10/12/2022 - 13:23 Newsletter subscribed - Progress in Mind Brazil newsletter Anonymous
User created Wed, 10/12/2022 - 13:23 User created Anonymous
Newsletter subscribed Wed, 10/12/2022 - 13:23 Newsletter subscribed - Progress in Mind Brazil newsletter Anonymous
User created Wed, 10/12/2022 - 13:23 User created Anonymous
Newsletter clicked Tue, 11/08/2022 - 12:04 Clicked https://brazil.progress.im/pt-br/content/equil%C3%ADbrio-vs-burnout-durante-covid-19 Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Apoio à saúde mental em tempos de crise Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Apoio à saúde mental em tempos de crise Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Dr. Mattingly discute abordagens durante a pandemia Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter clicked Tue, 11/08/2022 - 12:04 Clicked https://brazil.progress.im/pt-br/content/equil%C3%ADbrio-vs-burnout-durante-covid-19 Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous
Log Type Authored on Log Message Log Node Authored by
User created Wed, 10/12/2022 - 13:23 User created Anonymous
User created Wed, 10/12/2022 - 13:23 User created Anonymous
Newsletter opened Thu, 07/30/2020 - 03:57 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Thu, 07/30/2020 - 03:33 Opened Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
User created Wed, 10/12/2022 - 13:23 User created Anonymous
User created Wed, 10/12/2022 - 13:23 User created Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Convite Lundbeck Webinar Internacional Anonymous
Newsletter clicked Tue, 11/08/2022 - 12:04 Clicked https://brazil.progress.im/pt-br/content/novos-medicamentos-com-anticorpos-monoclonais-t%C3%AAm-como-alvo-cgrp-e-seus-receptores Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
OWA Status Wed, 10/12/2022 - 13:23 Updating trust level from 1 to 2 Anonymous
Newsletter subscribed Wed, 10/12/2022 - 13:23 Newsletter subscribed - Progress in Mind Brazil newsletter Anonymous
User created Wed, 10/12/2022 - 13:23 User created Anonymous
Newsletter subscribed Wed, 10/12/2022 - 13:23 Newsletter subscribed - Progress in Mind Brazil newsletter Anonymous
User created Wed, 10/12/2022 - 13:23 User created Anonymous
Newsletter clicked Tue, 11/08/2022 - 12:04 Clicked https://brazil.progress.im/pt-br/content/equil%C3%ADbrio-vs-burnout-durante-covid-19 Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Apoio à saúde mental em tempos de crise Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Apoio à saúde mental em tempos de crise Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Dr. Mattingly discute abordagens durante a pandemia Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter clicked Tue, 11/08/2022 - 12:04 Clicked https://brazil.progress.im/pt-br/content/equil%C3%ADbrio-vs-burnout-durante-covid-19 Novos medicamentos têm como alvo a CGRP e seus receptores Anonymous
Newsletter opened Wed, 10/12/2022 - 13:23 Opened Anonymous